
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
Xu‐Sheng Liu, Lu-Meng Zhou, Lingling Yuan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 91
Xu‐Sheng Liu, Lu-Meng Zhou, Lingling Yuan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 91
Showing 1-25 of 91 citing articles:
Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy
Mehrdad Hashemi, Marzieh Sadat Moosavi, Hedyeh Maghareh Abed, et al.
Pharmacological Research (2022) Vol. 184, pp. 106418-106418
Closed Access | Times Cited: 112
Mehrdad Hashemi, Marzieh Sadat Moosavi, Hedyeh Maghareh Abed, et al.
Pharmacological Research (2022) Vol. 184, pp. 106418-106418
Closed Access | Times Cited: 112
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 43
Shiwei Yue, Hailing Liu, Hong-Fei Su, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 43
Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer
Jinyan Wang, Dongmei Qin, Zhonghua Tao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
Jinyan Wang, Dongmei Qin, Zhonghua Tao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 42
METTL3 regulates TFRC ubiquitination and ferroptosis through stabilizing NEDD4L mRNA to impact stroke
Wenjie Su, Xiang Yu, Shan Wang, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 15
Wenjie Su, Xiang Yu, Shan Wang, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 15
AURKA inhibition induces Ewing’s sarcoma apoptosis and ferroptosis through NPM1/YAP1 axis
Huimou Chen, Jing Hu, Xilin Xiong, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Huimou Chen, Jing Hu, Xilin Xiong, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine
Ousman Bajinka, Serge Yannick Ouédraogo, Olga Golubnitschaja, et al.
The EPMA Journal (2024) Vol. 15, Iss. 2, pp. 289-319
Open Access | Times Cited: 10
Ousman Bajinka, Serge Yannick Ouédraogo, Olga Golubnitschaja, et al.
The EPMA Journal (2024) Vol. 15, Iss. 2, pp. 289-319
Open Access | Times Cited: 10
Progression of m6A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming
Xuan Han, Yu Zhu, Juan Ke, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Xuan Han, Yu Zhu, Juan Ke, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
m6A RNA methylation: a pivotal regulator of tumor immunity and a promising target for cancer immunotherapy
Xi Chen, Yixiao Yuan, Fan Zhou, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Xi Chen, Yixiao Yuan, Fan Zhou, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA
Xu‐Sheng Liu, Jian-Wei Yang, Jing Zeng, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 37
Xu‐Sheng Liu, Jian-Wei Yang, Jing Zeng, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 37
Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, et al.
Molecular Oncology (2022) Vol. 17, Iss. 2, pp. 195-229
Open Access | Times Cited: 28
The Cytidine N-Acetyltransferase NAT10 Participates in Peripheral Nerve Injury-Induced Neuropathic Pain by Stabilizing SYT9 Expression in Primary Sensory Neurons
Ming Zhang, Kehui Yang, Qihui Wang, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 17, pp. 3009-3027
Open Access | Times Cited: 19
Ming Zhang, Kehui Yang, Qihui Wang, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 17, pp. 3009-3027
Open Access | Times Cited: 19
Glycolysis induces Th2 cell infiltration and significantly affects prognosis and immunotherapy response to lung adenocarcinoma
Liping Zeng, Lu Liang, Xianlei Fang, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 3
Closed Access | Times Cited: 17
Liping Zeng, Lu Liang, Xianlei Fang, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 3
Closed Access | Times Cited: 17
Nucleophosmin plays a role in repairing DNA damage and is a target for cancer treatment
Konjeti R. Sekhar, Michael L. Freeman
Cancer Research (2023) Vol. 83, Iss. 10, pp. 1573-1580
Open Access | Times Cited: 16
Konjeti R. Sekhar, Michael L. Freeman
Cancer Research (2023) Vol. 83, Iss. 10, pp. 1573-1580
Open Access | Times Cited: 16
Tumor energy metabolism: implications for therapeutic targets
Youwu Hu, Wanqing Liu, WanDi Fang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 7
Youwu Hu, Wanqing Liu, WanDi Fang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 7
Role of m6A modifications in immune evasion and immunotherapy
Chunyu Wu, Lvyuan Li, Qiling Tang, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 6
Chunyu Wu, Lvyuan Li, Qiling Tang, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 6
Roles of m5C RNA Modification Patterns in Biochemical Recurrence and Tumor Microenvironment Characterization of Prostate Adenocarcinoma
Zhipeng Xu, Shuqiu Chen, Yuxi Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Zhipeng Xu, Shuqiu Chen, Yuxi Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
The regulation and potential roles of m6A modifications in early embryonic development and immune tolerance at the maternal-fetal interface
Hong Liu, Jie Zheng, Aihua Liao
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Hong Liu, Jie Zheng, Aihua Liao
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Discovery of drug targets and therapeutic agents based on drug repositioning to treat lung adenocarcinoma
Occam Kelly Graves, Woonghee Kim, Mehmet Özcan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114486-114486
Open Access | Times Cited: 11
Occam Kelly Graves, Woonghee Kim, Mehmet Özcan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114486-114486
Open Access | Times Cited: 11
Delivery of miR-15b-5p via magnetic nanoparticle-enhanced bone marrow mesenchymal stem cell-derived extracellular vesicles mitigates diabetic osteoporosis by targeting GFAP
Chen Xu, Zhaodong Wang, Yajun Liu, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 4
Chen Xu, Zhaodong Wang, Yajun Liu, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 4
FKBP Prolyl Isomerase 11: A Novel Oncogene Interacting With SRSF1 in Esophageal Squamous Cell Carcinoma
Zheng Ding, Zhichao Hou, Tangjuan Zhang, et al.
Molecular Carcinogenesis (2025)
Closed Access
Zheng Ding, Zhichao Hou, Tangjuan Zhang, et al.
Molecular Carcinogenesis (2025)
Closed Access
Exploratory analysis of a Novel RACK1 mutation and its potential role in epileptic seizures via Microglia activation
Sai Zhang, Zhaofei Dong, Jiafu Ji, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
Sai Zhang, Zhaofei Dong, Jiafu Ji, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
Expression patterns of MCM8 in lung adenocarcinoma and its correlation with key biological processes
Xu‐Sheng Liu, Jin Xie, Ruimin Wu, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Xu‐Sheng Liu, Jin Xie, Ruimin Wu, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
CAF‐derived exosomal LINC01711 promotes breast cancer progression by activating the miR‐4510/NELFE axis and enhancing glycolysis
Shuang Tao, Yali Gao, Xiang Wang, et al.
The FASEB Journal (2025) Vol. 39, Iss. 7
Closed Access
Shuang Tao, Yali Gao, Xiang Wang, et al.
The FASEB Journal (2025) Vol. 39, Iss. 7
Closed Access
Comprehensive analysis of prognosis and tumor immune microenvironment of cuproptosis-related gene CDKN2A in lung adenocarcinoma
Teng Song, Shuping Li, Ke Zhao, et al.
BMC Pulmonary Medicine (2025) Vol. 25, Iss. 1
Open Access
Teng Song, Shuping Li, Ke Zhao, et al.
BMC Pulmonary Medicine (2025) Vol. 25, Iss. 1
Open Access